Mode
Text Size
Log in / Sign up
N/A N=34 Randomized Single-blind Treatment

Forced Aerobic Exercise for Stroke Rehabilitation

Stroke

Enrolled (actual)
34
Serious AEs
2.9%
Results posted
Mar 2019
Primary outcome: Primary: Fugl Meyer Assessment — 6.90; 4.00; 6.25; 10.10 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Forced Exercise & Upper Extremity Repetitive Task Practice (Behavioral); Voluntary Exercise & Upper Extremity Repetitive Task Practice (Behavioral); Stroke Education & Upper Extremity Repetitive Task Practice (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The Cleveland Clinic
Primary completion
Aug 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Fugl Meyer Assessment
6.90; 4.00; 6.25; 10.10; 6.50; 8.88
PRIMARY
Wolf Motor Function Test
7.80; 6.40; 10.50; 9.22; 9.60; 10.88
PRIMARY
Stroke Impact Scale
15.00; 14.50; 9.38; 19.44; 14.00; 21.25
PRIMARY
Metabolic Stress Test
0.02; 1.09; 0.40
SECONDARY
Action Research Arm Test
8.60; 6.30; 6.38; 8.56; 7.50; 7.13
SECONDARY
Center for Epidemiological Studies-Depression
-5.20; -0.30; -2.00; -3.67; -2.60; -3.75
SECONDARY
Processing Speed Test
0.90; 1.88; 2.71; 2.89; 3.25; 6.38
SECONDARY
Nine Hole Peg Test
-8.07; -16.15; -19.35; -8.10; -7.81; -29.15
SECONDARY
Six Minute Walk Test
133.20; 188.70; -21.75; 78.50; 127.70; 78.88

Summary

The purpose of the study is to determine if performing different types of aerobic exercise (cycling) before upper extremity exercises will help to improve outcomes after stroke.

Eligibility Criteria

Inclusion Criteria

  • Able to provide informed consent
  • At least 6 months post diagnosis of single ischemic stroke, confirmed with neuroimaging
  • Fugl-Meyer Motor Score 19-55 in involved upper extremity
  • Approval from patient's physician
  • Age between 18 and 85 years

Exclusion Criteria

  • Hospitalization for myocardial infarction, congestive heart failure, or heart surgery (CABG or valve replacement) within 3 months of study enrollment
  • Serious cardiac arrhythmia
  • Other serious heart and lung conditions (i.e.cardiomyopathy, aortic stenosis, cardiac pacemaker, pulmonary embolus)
  • Other medical or musculoskeletal contraindication to exercise
  • Significant cognitive impairment (unable to follow 1-2 step commands) or major psychiatric disorder (major depression, generalized anxiety) that will cause difficulty in study participation
  • Anti-spasticity injection (botox) in upper extremity within 3 months of study enrollment
  • Pregnancy
  • Unstable blood pressure at rest or with exercise
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02494518). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search